Emerging role of microRNAs in mTOR signaling
Y Zhang, B Huang, HY Wang, A Chang… - Cellular and Molecular …, 2017 - Springer
Mechanistic target of rapamycin (mTOR) is a conserved serine/threonine kinase that plays a
critical role in the control of cellular growth and metabolism. Hyperactivation of mTOR …
critical role in the control of cellular growth and metabolism. Hyperactivation of mTOR …
DEPTOR at the nexus of cancer, metabolism, and immunity
DEP domain-containing mechanistic target of rapamycin (mTOR)-interacting protein
(DEPTOR) is an important modulator of mTOR, a kinase at the center of two important …
(DEPTOR) is an important modulator of mTOR, a kinase at the center of two important …
Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a/Galectin-3+ neurodegenerative …
Single cell RNA sequencing studies identified novel neurodegeneration-associated
microglial (MGnD/DAM) subtypes activated around cerebral amyloid plaques. Micro-RNA …
microglial (MGnD/DAM) subtypes activated around cerebral amyloid plaques. Micro-RNA …
An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations
N Pulliam, F Fang, AR Ozes, J Tang, A Adewuyi… - Clinical Cancer …, 2018 - AACR
Purpose: PARP inhibitors (PARPi) are primarily effective against BRCA1/2-mutated breast
and ovarian cancers, but resistance due to reversion of mutated BRCA1/2 and other …
and ovarian cancers, but resistance due to reversion of mutated BRCA1/2 and other …
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
L Li, GM Pilo, X Li, A Cigliano, G Latte, LI Che… - Journal of …, 2016 - Elsevier
Background & Aims Cumulating evidence underlines the crucial role of aberrant lipogenesis
in human hepatocellular carcinoma (HCC). Here, we investigated the oncogenic potential of …
in human hepatocellular carcinoma (HCC). Here, we investigated the oncogenic potential of …
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
Background mTOR inhibition of aromatase inhibitor (AI)-resistant breast cancer is currently
under evaluation in the clinic. Everolimus/RAD001 (Afinitor®) has had limited efficacy as a …
under evaluation in the clinic. Everolimus/RAD001 (Afinitor®) has had limited efficacy as a …
Lifetime impact of cow's milk on overactivation of mTORC1: From fetal to childhood overgrowth, acne, diabetes, cancers, and neurodegeneration
BC Melnik - Biomolecules, 2021 - mdpi.com
The consumption of cow's milk is a part of the basic nutritional habits of Western
industrialized countries. Recent epidemiological studies associate the intake of cow's milk …
industrialized countries. Recent epidemiological studies associate the intake of cow's milk …
Tunneling nanotubes mediated microRNA-155 intercellular transportation promotes bladder cancer cells' invasive and proliferative capacity
JJ Lu, WM Yang, F Li, W Zhu, Z Chen - International journal of …, 2019 - Taylor & Francis
Objective To investigate differential microRNAs' expression in heterogeneous bladder
cancer cells, as well as to investigate the mechanism of changes in invasive and …
cancer cells, as well as to investigate the mechanism of changes in invasive and …
MiR155 modulates vascular calcification by regulating Akt‐FOXO3a signalling and apoptosis in vascular smooth muscle cells
Y Li, W Sun, F Saaoud, Y Wang, Q Wang… - Journal of Cellular …, 2021 - Wiley Online Library
Abstract microRNA‐155 (miR155) is pro‐atherogenic; however, its role in vascular
calcification is unknown. In this study, we aim to examine whether miR155 regulates …
calcification is unknown. In this study, we aim to examine whether miR155 regulates …
Lost but not least—novel insights into progesterone receptor loss in estrogen receptor-positive breast cancer
Simple Summary Most breast cancers co-express estrogen receptor α (ERα) and
progesterone receptor (PgR). These cancers are sensitive to endocrine therapy and, in …
progesterone receptor (PgR). These cancers are sensitive to endocrine therapy and, in …